Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing to sign a consent form and voluntarily take part in the study
- People who have been diagnosed with epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer, confirmed through a tissue or cell sample test
- People who are 18 years of age or older
- People whose doctor determines they are suitable to receive the study drug fluzoparib, either on its own or combined with another treatment
- People who are capable of becoming pregnant must use effective contraception throughout the study and for 90 days after the last dose of fluzoparib
Who may not be able to join:
- People who are currently pregnant or breastfeeding
- People who are already taking part in another clinical study that involves an intervention beyond standard routine care
- People whose doctor determines there are other reasons that make participation in this study unsuitable (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
incidence of ≥ grade 3 Hematology related adverse event according to NCI CTCAE v5.0
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.